| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 01/08/2003 | EP1272610A1 Mutant bank |
| 01/08/2003 | EP0805857A4 Method for generating proteolytic enzymes specific against a selected peptide sequence |
| 01/08/2003 | EP0751996B1 Luciferases |
| 01/08/2003 | EP0607309B1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 01/08/2003 | CN1390252A Fungamyl-like alpha-amylase variants |
| 01/08/2003 | CN1390226A Preparation of a macrocyclic lactone |
| 01/08/2003 | CN1390141A Nucleic acid-containing complex |
| 01/07/2003 | US6503888 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/07/2003 | US6503709 Detection the presence of an antibiotic resistant mecA gene in a biological sample, comprising the general steps of (a) treating cells contained within a biological sample to expose target single- stranded nucleic acid molecules; (b) reacting |
| 01/07/2003 | US6503505 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 01/07/2003 | US6503499 Viral particle comprising gene of interest operably linked to a promoter and envelope protein affixed with bifunctional adapter and a biotin molecule; internalizing into target cell for transduction and gene expression |
| 01/07/2003 | CA2269771C Novel bacterial strains and use thereof in fermentation processes for 2-keto-l-gulonic acid production |
| 01/07/2003 | CA2257581C Biodegradation of metal cyanides |
| 01/07/2003 | CA2190373C Yeast strains |
| 01/07/2003 | CA2113363C Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 01/07/2003 | CA1341415C Targeted multifunctional proteins |
| 01/03/2003 | WO2003000912A1 A process for the preparation of gallic acid by co-culture |
| 01/03/2003 | WO2003000911A1 Process for producing optically active (r)-2-chloro-1-(3'-chlorophenyl)ethanol |
| 01/03/2003 | WO2003000910A2 Metabolic controlled fermentation process for pseudomonic acid production |
| 01/03/2003 | WO2003000880A2 Homoaconitase as a target for fungicides |
| 01/03/2003 | WO2003000875A2 Vitamin b6-phosphate phosphatase |
| 01/03/2003 | WO2003000868A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/03/2003 | WO2002083062A3 Process for the production of piperidine derivatives with microorganisms |
| 01/03/2003 | WO2002055725A9 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 01/03/2003 | WO2002040706A3 Method and medium for detecting/identifying micro-organisms |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2001098470A3 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same |
| 01/03/2003 | WO2001083800A8 Heterologous production of polyketides |
| 01/03/2003 | WO2001081581A9 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/03/2003 | WO2001064899A8 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 01/03/2003 | CA2451486A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/03/2003 | CA2450792A1 Homoaconitase as a target for fungicides |
| 01/03/2003 | CA2449378A1 Vitamin b6-phosphate phosphatase |
| 01/03/2003 | CA2448547A1 Metabolic controlled fermentation process for pseudomonic acid production |
| 01/02/2003 | US20030005488 Propagation of fungal foods; generate nutrient broth, inoculate with fingus, propagate and recover fungal nutrients |
| 01/02/2003 | US20030005480 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same |
| 01/02/2003 | US20030004091 Medicinal combination useful for in vivo exogenic transfection and expression |
| 01/02/2003 | US20030003569 Removal of phenanthrene or chrysene for waste; obtain waste, incubate with fungus, analyses waste for removal of phenanthrene or chrysene |
| 01/02/2003 | US20030003556 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
| 01/02/2003 | US20030003550 Microorganism for use in the generation of glutamine; for use in maintaining liver health |
| 01/02/2003 | US20030003528 Generation of carotenoid compound; obtain gnetically engineeered cell, incubate with carbon substrate, recover carotene compound |
| 01/02/2003 | US20030003511 Closure of bacterial ghost |
| 01/02/2003 | US20030003112 Avipox virus containing foreign DNA from porcine reproductive and respiratory syndrome virus; immunological compositions containing the recombinant poxvirus for inducing an immunological response in a host animal |
| 01/02/2003 | US20030003101 Treatment and diagnosis of prostate cancer |
| 01/02/2003 | EP1270728A1 Process for producing avermectin derivative |
| 01/02/2003 | EP1270720A2 Activated rec-D-Hydantoinases |
| 01/02/2003 | EP1270719A2 Cell population containing non-fetal hemangioblasts and method for producing same |
| 01/02/2003 | EP1270718A1 Cell culturing method and device |
| 01/02/2003 | EP1270593A2 HSCA-3 antigen and monoclonal antibody which recognizes the antigen |
| 01/02/2003 | EP1268844A1 Modulating production of pneumococcal capsular polysaccharide |
| 01/02/2003 | EP1268839A1 Beta-glucans from filamentous fungi |
| 01/02/2003 | EP1268835A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 01/02/2003 | EP1268813A2 Thermophilic polymerase iii holoenzyme |
| 01/02/2003 | EP1268808A1 Mutants of lactobacillus casei defective in carbon catabolism regulation |
| 01/02/2003 | EP1268798A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 01/02/2003 | EP1268783A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 01/02/2003 | EP1268764A2 Method for obtaining nucleic acids from an environment sample |
| 01/02/2003 | EP1268757A1 Nitrilase from rhodococcus rhodochrous ncimb 11216 |
| 01/02/2003 | EP1268752A1 Production of lutein in microorganisms |
| 01/02/2003 | EP1268750A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 01/02/2003 | EP1268745A2 Method for supply of starter cultures having a consistent quality |
| 01/02/2003 | EP1268420A1 Chemokine receptor antagonists |
| 01/02/2003 | EP1267626A1 Recombinant parainfluenza virus expression systems and vaccines |
| 01/02/2003 | EP0745131B1 Targeting gene therapy |
| 01/02/2003 | EP0723592B1 Alpha-1,4-glucan lyase from a fungus infected algae, its purification, gene cloning and expression in microorganisms |
| 01/02/2003 | EP0630408B1 PRODUCTION OF $i(ASPERGILLUS NIGER CATALASE-R) |
| 01/02/2003 | EP0628074B1 In vitro activation of cytotoxic t cells |
| 01/01/2003 | CN1388830A Process for prodcing carotenoid pigments |
| 01/01/2003 | CN1388250A Process for producing L-glutaminic acid |
| 01/01/2003 | CN1097635C Fermentative production and isolation of lactic acid |
| 01/01/2003 | CN1097632C A mutant E. coli strain with increased succinic acid production |
| 01/01/2003 | CN1097466C Living salmonella vaccine |
| 12/31/2002 | US6501007 Inhibiting expression of an rna transcription product of the d1 gene of given sequence using an antisense oligonucleotide; controlling daikoku type dwarfism gene d1 expression |
| 12/31/2002 | US6501005 DNA sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants |
| 12/31/2002 | US6500932 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same |
| 12/31/2002 | US6500931 Portion of a complementarity determining region (cdr) derived from a non-human antibody with remaining portions human in origin; use in immunotherapy or as immunotoxins |
| 12/31/2002 | US6500923 Isolated polypeptide that binds to an autoantibody from a dermatomyositis patient to provide means by which dermatomyositis can be detected by way of differential diagnosis |
| 12/31/2002 | US6500919 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 12/31/2002 | US6500674 Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications |
| 12/31/2002 | US6500664 Growth differentiation factor-8 family nucleic acid sequences |
| 12/31/2002 | US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones |
| 12/31/2002 | US6500661 Enzymatic synthesis of gdp-fucose, which can be used in fucosylation reactions; the reaction mixture comprising gdp-4-keto-6-deoxymannose, nadph, and a prokaryotic enzyme with epimerase and reductase activity |
| 12/31/2002 | US6500659 A thermostable enzyme that catalyzes the removal of arginine, phenylalanine, or methionine from the n-terminal end of peptides |
| 12/31/2002 | US6500651 Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid |
| 12/31/2002 | US6500647 Recombinant expression vector which is prepared by inserting a human parathyroid hormone gene containing a urokinase-specific cleavage site into an l-arabinose inducible vector containing a phosphoribulokinase gene fragment of |
| 12/31/2002 | US6500634 Neurotransmission by excitatory amino acids (eaas) such as glutamate is mediated via membrane-bound surface receptors. dna coding for eaa receptors of one family of human nmda-binding type receptors has now been isolated and receptor |
| 12/31/2002 | US6500624 Kainate-binding, human CNS receptors of the EAA3 family |
| 12/31/2002 | US6500617 Recombining plurality of nucleic acids comprising segments derived from a gene that confers resistance to pests such as insects producing a library; expressing encoded polypeptides and assaying |
| 12/31/2002 | US6500467 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500463 Mixing plasticizable matrix material, liquid plasticizer, encapsulant, non-plasticizable non-gelatinized starch, and component for controlling rate of release of encapsulant under low shear and low temperature, forming into pieces, drying |
| 12/31/2002 | US6500424 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500423 Probiotic composition comprising viable escherichia coli strain bu-230-98 atcc deposit no. 20226 (dsm 12799) and a formulation for maintaining viability of said escherichia coli strain |
| 12/31/2002 | CA2249635C Detection of neisseria gonorrhoeae by amplification and detection of its nucleic acid |
| 12/31/2002 | CA2201944C Analogs of keratinocyte growth factor having enhanced temperature stability |
| 12/31/2002 | CA2157867C High molecular weight surface proteins of non-typeable haemophilus |
| 12/31/2002 | CA2096532C New human recombinant gamma-interferon |
| 12/31/2002 | CA2069460C Methods and compositions for preparation and use of a herpes protease |
| 12/27/2002 | WO2002103060A2 Enterovirus nucleic acids and methods for detecting enterovirus |
| 12/27/2002 | WO2002103040A1 Viral drug susceptibility testing |
| 12/27/2002 | WO2002103038A1 Enzymatic method of producing 4-0-b-d galactopyranosyl-d-xylose, 4-0-b-d-galactopyranosyl-d-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase |